<DOC>
	<DOCNO>NCT01352611</DOCNO>
	<brief_summary>The purpose study determine intrathecal administration baclofen reduce symptom severe tactile defensiveness autism spectrum disorder .</brief_summary>
	<brief_title>Open Label Treatment Severe Tactile Defensiveness With Intrathecal Baclofen</brief_title>
	<detailed_description>The purpose study determine intrathecal administration baclofen reduce symptom severe tactile defensiveness autism spectrum disorder . Some people autism spectrum disorder like touch . This refer tactile defensiveness . Baclofen drug approve treatment spasticity patient condition cerebral palsy , spinal cord injury traumatic brain injury . Intrathecal mean baclofen administer injection spinal canal . In study , patient undergo trial administration intrathecal baclofen effect intrathecal baclofen symptom tactile defensiveness autism spectrum disorder evaluate . Each patient three visit connection study . First , screen visit investigator determine patient eligible participate study . To participate , patient must autism spectrum disorder , severe tactile defensiveness , meet list criterion . At second visit , patient undergo intrathecal baclofen trial procedure . The procedure use standard procedure determine intrathecal baclofen effective treatment spasticity . In study however , instead evaluate effect intrathecal baclofen spasticity , investigator evaluate effect intrathecal baclofen symptom tactile defensiveness autism spectrum disorder . The trial procedure evaluation require one day . At third visit , follow visit , investigator evaluate discuss patient 's response treatment .</detailed_description>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<criteria>1 . Diagnosis autism prior study entry 2 . Exhibits specific symptom autism : Tactile Defensiveness Increased sensitivity sensory stimulation 3 . Patients must score `` Always '' `` Reacts emotionally aggressively touch '' modify Short Sensory Profile Questionnaire . Additionally , patient must score `` Always '' `` Frequently '' category modify Short Sensory Profile Questionnaire 1 . Allergy baclofen compound similar structure 2 . Unable evaluated chosen efficacy measure 3 . Any condition opinion principal investigator place patient increase risk adverse event preclude completion study 4 . Concomitant use medication opinion principal investigator contraindicate intrathecal baclofen administration 5 . Females childbearing potential positive urine pregnancy test visit 2</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Tactile Defensiveness</keyword>
	<keyword>Autistic Disorder</keyword>
</DOC>